New sedation combo may improve awake brain surgery experience
NCT ID NCT07513935
First seen Apr 23, 2026 · Last updated Jun 17, 2026 · Updated 10 times
Summary
This study tests whether adding ketamine to dexmedetomidine sedation improves comfort and brain signal quality during awake deep brain stimulation (DBS) surgery for movement disorders like Parkinson's disease. About 24 adults will be randomly assigned to receive either the combination or dexmedetomidine alone. The goal is to find a safer, more effective sedation approach that keeps patients calm yet responsive during the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ainshams University
Cairo, Egypt
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.